Wealth Enhancement Advisory Services
SLS icon

Wealth Enhancement Advisory Services’s SELLAS Life Sciences SLS Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio SLS Stock Details SLS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		– Sell
-10,203
Closed -$130K – 4420
2026
Q2 		$130K Buy
+10,203
New +$70.4K ﹤0.01% 3737

Other funds holding SLS

EFG
Everhart Financial Group Dublin, Ohio $1.62B AUM 25.73% 1-Year Est. Return
EM
ELCO Management New York $213M AUM 25.23% 1-Year Est. Return
IFG
Independent Financial Group San Diego, California $5.51B AUM 33.52% 1-Year Est. Return
RI
Ridgewood Investments Springfield, New Jersey $271M AUM
FD
Financial Designs Claremont, California $194M AUM 10.52% 1-Year Est. Return
FFBTD
First Financial Bank - Trust Division Hamilton, Ohio $1.39B AUM 15.59% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
CA
CoreCap Advisors Southfield, Michigan $3.48B AUM 21.43% 1-Year Est. Return
AAG
Armstrong Advisory Group Needham, Massachusetts $1.66B AUM 13.15% 1-Year Est. Return

Wealth Enhancement Advisory Services's SLS Position: Q3 2026 in Review

Wealth Enhancement Advisory Services sold out of SELLAS Life Sciences (SLS) in Q3 2026, closing a stake of 10,203 shares — an estimated $130K sold.

Wealth Enhancement Advisory Services first reported a position in SLS in Q2 2026 and held it in 1 quarter. The position peaked at $130K in Q2 2026. 13 funds tracked by Wall St. Rank hold SLS as of Q3 2026.

  • Wealth Enhancement Advisory Services reported no remaining SELLAS Life Sciences position as of Q3 2026 after selling out during the quarter.
  • Wealth Enhancement Advisory Services sold 10,203 SELLAS Life Sciences shares in Q3 2026, an estimated $130K.
  • Wealth Enhancement Advisory Services first reported a position in SELLAS Life Sciences in Q2 2026 and held it in 1 quarter.
  • Wealth Enhancement Advisory Services's SELLAS Life Sciences position peaked at $130K in Q2 2026.
  • 13 funds tracked by Wall St. Rank held SELLAS Life Sciences as of Q3 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q3 2026, filed 13 Oct 2026.